Share this @internewscast.com
Watch Dateline’s documentary ‘Born Big’ on 3 June at 9.30pm on SBS or SBS On Demand.
By her 12th birthday, Lexi weighed 116kg — almost three times the average weight of an American girl her age.

At the age of 13, Lexi underwent bariatric surgery, where 80 per cent of her stomach was removed. She initially lost 29kg. However, nine months post-surgery, she regained some weight, and her significant hunger returned.

Lexi has MC4R gene deficiency. It disrupts the brain’s ability to regulate appetite, resulting in weight gain and a constant feeling of insatiable hunger.
Nearly three years after her surgery, Lexi, now 15, is exploring alternative options.
“I’d like to be a size where I can go out and play sports again, like I used to when I was younger,” she says.

Recently, Lexi was prescribed Wegovy, a weight-loss medication approved by the US Food and Drug Administration (FDA) to treat obesity in individuals aged 12 and older.

A teenage girl in a black sweater holding a toy reindeer

Lexi after her bariatric surgery in which 80 per cent of her stomach was removed. Source: Supplied

Wegovy belongs to the new class of injectable medications, originally used for the treatment of Type 2 diabetes but now FDA-approved for long-term weight management.

These drugs — primarily semaglutide (Wegovy and Ozempic) and tirzepatide (marketed under the brand names Mounjaro and Zepbound) — mimic GLP-1 hormones that regulate blood sugar and appetite, helping patients feel fuller for longer. They have been popularised by celebrities and on social media.
According to a 2024 study published in the Journal of the American Medical Association, prescriptions of these drugs for teens and young adults in the United States increased by 600 per cent between 2020 and 2023 — with the overwhelming majority being teenage girls.
One in five children and adolescents in the US are affected by obesity.

In January 2023, the American Academy of Pediatrics (AAP), which is the largest professional association of pediatricians in the US, revised its guidelines for treating children with obesity for the first time in 15 years, now endorsing early medical interventions like surgery and weight-loss medications, alongside lifestyle and behavior modifications.

A teenage girl wearing a white-and-blue printed t-shirt and black shorts standing next to a house

Lexi, now 15, has been able to lose some weight with an appetite suppressant. She is, however, on the insurance waitlist for the weight loss drug Wegovy. Source: Supplied

Dr Fatima Cody Stanford, an obesity medicine physician and an associate professor at Harvard Medical School, says there’s been “a noticeable shift in recent years in how obesity and obesity medications are discussed within the paediatric and broader medical fields”.

“There is growing recognition of obesity as a complex, chronic disease rather than a simple consequence of lifestyle choices,” she says.
“The increasing visibility and acceptance of pharmacological treatments as legitimate components of obesity management reflect this change, although stigma still exists and must be continually addressed.”

However, she says irreversible treatment such as bariatric surgery and indefinite use of medication at age 12 “must be approached with caution”. It’s important to balance the potential benefits of anti-obesity drugs against the unknown long-term effects, she says.

“I advise families to consider the improvement in quality of life and reduction in obesity-related health risks as significant benefits,” she says.

“However, the psychological and emotional aspects, such as body image, potential dependence on medication, and identity formation, should be openly discussed.”

High cost of weight-loss drugs

Lexi’s mum Brandy was initially against injectable GLP-1 drugs. “I wanted her to be a little older,” she says.
Now, looking back, she says she would have started with medication rather than surgery for Lexi.

“Surgery is final … there’s no reversing it,” she says, adding that she believes bariatric surgery remains an essential option if other treatments fall short.

A blonde woman wearing dark-framed prescription glasses and a black sweater with a floral print stands next to a teenage girl wearing a grey t-shirt

American mother and daughter Brandy and Lexi are looking for obesity treatment that would work for Lexi, who has a genetic disorder that prevents her from weight loss Source: SBS / Colin Cosier

Bariatric surgery usually leads to substantial weight loss, but Lexi’s MC4R deficiency made her procedure far less effective.

“The conversation is changing,” Brandy says. “I remember the first weight loss hospital we went to, they literally just gave us a portion plate and sent us home.”
Now, “the availability and the options for people, it’s great, [and] it needs to keep going.”
In April, Lexi was prescribed Wegovy. But the family has been locked in a battle with their insurance provider to secure even partial coverage for the medication’s cost.

Despite more weight-loss drugs hitting the market, many people in the US still can’t afford them.

A month’s supply of Wegovy, for example, can cost approximately US$1,350 ($2,100) — that’s over US$16,000 ($25,000) each year.

Medicare, the federal health insurance, is prohibited from covering weight-loss drugs by law. Most private health plans don’t cover them either, primarily, due to their high cost. Bariatric surgery, on the other hand, is covered by insurance companies.

In April, the Trump administration rejected a Biden-era proposal to expand Medicare coverage of anti-obesity drugs such as Wegovy.
However, GLP-1 drugs have become a target of a new executive order, signed by US President Donald Trump in May, aimed at lowering prescription drug prices, which are notoriously high in the US compared to other developed nations.
In the meantime, Lexi has seen some progress with an oral appetite suppressant, Qsymia, to help regulate her hunger. She’s lost weight and had her obesity reduced from class 3 to class 2.
But the journey has been mentally draining, she says.
“You just feel kind of defeated because, you’re like, what am I supposed to do when my options run out?”
Share this @internewscast.com
You May Also Like
President Donald Trump speaks during a cabinet meeting at the White House, Tuesday, July 8, 2025, in Washington. (AP Photo/Evan Vucci)

Trump Considers Doubling Tariffs on Australia

US President Donald Trump has declared his intention to impose a 35…
Bluey coin

Bluey Thieves Await Judgment After Stealing 63,000 Coins

Two men are set to spend several months in jail awaiting their…
A depiction of the new Frenchs Forest town centre.

Northern Sydney Suburb Revitalized: From Brick Pit to Lush Green Oasis

From early brick quarry grit and grime to a new green space,…
Chermside hit-run

Brisbane Hit-and-Run: Tradie Involved in Fatal Accident May Be Released Soon

A Queensland tradie was sentenced to five years jail today for killing…
Geologist James Hagadorn closes boxes of core rock samples at the Denver Museum of Nature & Science on July 9, 2025. (AP Photo/Thomas Peipert)

Discovery Made by US Dinosaur Museum Beneath Its Parking Lot

A US museum famous for its dinosaur exhibits has discovered a fossil…
Police suspect AFL star's car was used in drive-by shooting

Authorities Believe AFL Player’s Car Involved in Drive-By Shooting

Exclusive: 9News can report that Jamarra Ugle-Hagan, the Bulldogs star who is…

Follow-up: Video of Corgi on Apartment Balcony Raises Worries

A corgi has been surrendered and is now in the care of…

Carolina Wilga: Latest Updates on the Disappearance of a German Backpacker

There are grave concerns for German backpacker Carolina Wilga, who disappeared while…
Trump hand-picks Aussie politician turned 'alpha male' for diplomatic role

Trump Selects Former Australian Politician, Now ‘Alpha Male,’ for Diplomatic Position

A former Sydney councillor, who once faced suspension from the Liberal Party,…
A car crash in Adelaide.

Motorist in fatal accident that claimed a mother’s life escapes life imprisonment

An Adelaide woman lost her life in a tragic accident with an…

“Brazil’s President Threatens Equivalent Retaliation to Trump’s Tariff Plan, Vows ‘We’ll Impose a 50% Charge'”

Brazil’s President Luiz Inacio Lula da Silva expressed his desire for a…
Multiple cars hit during high-speed police chase across Melbourne freeways

Several Vehicles Struck in High-Speed Police Pursuit on Melbourne Highways

Authorities have apprehended a suspect accused of seizing a van and initiating…